Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Post-Acute COVID-19 SyndromeCognitive Dysfunction
Interventions
DEVICE

Pascal device

The study devices consist of a tabletop Console with user interface and a head-worn applicator (Headset) that is connected via coaxial cable. The Headset is positioned on the head per instructions, and then the study subject powers on the device by pressing the power button and initiates a 15-minute treatment by pressing the start button. LED lights on the console count down during the treatment to indicate time remaining and, once the treatment is complete, the device automatically powers off.

DEVICE

Sham Device

The sham device will look identical to the active device and will have the same indicator lights and sounds, but will not emit magnetic field therapy.

Trial Locations (1)

10029

RECRUITING

The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE), New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Humanity Neurotech Inc.

UNKNOWN

lead

Icahn School of Medicine at Mount Sinai

OTHER